Search Within

Takeshi Shimamura

Refine Results
  1. "AACR"
Formats
  1. Journal Article (7)
Groups
  1. Cardinal Bernardin Cancer Center (7)
  2. Oncology Research Institute (7)
People
  1. Michael Nishimura (1)
  2. Simon Kaja (1)
  3. Wei Qiu (1)
Years
  1. 2020 (1)
  2. 2016 (1)
  3. 2013 (3)
  4. 2012 (2)
Journals
  1. Cancer research (4)
  2. Clinical cancer research : an official journal of the American Association for Cancer Research (2)
  3. Cancer discovery (1)
Publishers
  1. AACR (7)

Results (7)

  • Endothelin-1-mediated Drug Resistance in EGFR-mutant NSCLC.
    Journal Article

    Pulido, I; Ollosi, S; Aparisi, S; Becker, JH; Aliena-Valero, A; Benet, M; Rodríguez, ML; López, A; Tamayo-Torres, E; Chuliá-Peris, L; more...
    Cancer research (2020)

    Find It @ Loyola | Save
  • Heterogeneity in Tumors and Resistance to EGFR TKI Therapy-Response
    Journal Article

    Shimamura, T
    Cancer research (2016)

    Find It @ Loyola | Save
  • Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors
    Journal Article

    Akbay, E. A.; Koyama, S.; Carretero, J; Altabef, A.; Tchaicha, J. H.; Christensen, C. L.; Mikse, O. R.; Cherniack, A. D.; Beauchamp, E. M.; Pugh, T. J.; more...
    Cancer discovery (2013)

    Find It @ Loyola | Save
  • Resistance to irreversible EGF receptor tyrosine kinase inhibitors through a multistep mechanism involving the IGF1R pathway
    Journal Article

    Cortot, A. B.; Repellin, C. E.; Shimamura, T; Capelletti, M.; Zejnullahu, K.; Ercan, D.; Christensen, J. G.; Wong, K. K.; Gray, N. S.; Janne, P. A.
    Cancer research (2013)

    Find It @ Loyola | Save
  • Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer
    Journal Article

    Shimamura, T; Chen, Z; Soucheray, M; Carretero, J; Kikuchi, E.; Tchaicha, J. H.; Gao, Y; Cheng, K. A.; Cohoon, T. J.; Qi, J.; more...
    Clinical cancer research : an official journal of the American Association for Cancer Research (2013)

    Find It @ Loyola | Save
  • Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer
    Journal Article

    Shimamura, T; Perera, S. A.; Foley, K. P.; Sang, J.; Rodig, S. J.; Inoue, T.; Chen, L; Li, D; Carretero, J; Li, Y. C.; more...
    Clinical cancer research : an official journal of the American Association for Cancer Research (2012)

    Find It @ Loyola | Save
  • Combined EGFR/MET or EGFR/HSP90 inhibition is effective in the treatment of lung cancers codriven by mutant EGFR containing T790M and MET
    Journal Article

    Xu, L; Kikuchi, E.; Xu, C.; Ebi, H.; Ercan, D.; Cheng, K. A.; Padera, R.; Engelman, J. A.; Janne, P. A.; Shapiro, G. I.; more...
    Cancer research (2012)

    Find It @ Loyola | Save